The convergence of precision oncology and the radiotherapy market heralds a new era in cancer treatment—one characterized by a synergistic approach that holds the promise of unprecedented therapeutic precision and patient outcomes. Precision oncology, which tailors medical decisions and interventions to the individual characteristics of each patient and their cancer, is now intersecting with the radiotherapy market, revolutionizing how cancer care is conceived and delivered.
